MITF and melanoma: It is well established that on treatment with MAPK inhibitors, increased MITF expression mediates melanoma cell survival (Haq, Yokoyama, et al., 2013; Johannessen et al., 2013; Rose et al., 2016; Smith et al., 2013, 2016, 2017; Song et al., 2017).